| Anastasia K Ketko, MD | |
|
9325 Upland Lane N, Suite 360, Maple Grove, MN 55369 | |
| (612) 813-6475 | |
| Not Available |
| Full Name | Anastasia K Ketko |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 9325 Upland Lane N, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548434772 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 4301097959 (Michigan) | Secondary |
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 57795 (Minnesota) | Primary |
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
Healthcare organizations are embracing the need for information transparency to drive clinical transformation, but they still require the tools and capabilities to make data available in real time and reduce the burden on scarce resources.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
Just weeks after Sierra Leone discharged its last patient, a new study reflects on the lessons learnt from the recent outbreak of Ebola, comparing it with that of AIDS in Africa in the early 1980s.
Today Biogen Idec reported top-line results of EMPOWER, a Phase 3 trial investigating dexpramipexole in people with amyotrophic lateral sclerosis (ALS).
› Verified 7 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Healthcare organizations are embracing the need for information transparency to drive clinical transformation, but they still require the tools and capabilities to make data available in real time and reduce the burden on scarce resources.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
Just weeks after Sierra Leone discharged its last patient, a new study reflects on the lessons learnt from the recent outbreak of Ebola, comparing it with that of AIDS in Africa in the early 1980s.
Today Biogen Idec reported top-line results of EMPOWER, a Phase 3 trial investigating dexpramipexole in people with amyotrophic lateral sclerosis (ALS).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anastasia K Ketko, MD 9325 Upland Lane N, Suite 360, Maple Grove, MN 55369 Ph: (612) 813-6475 | Anastasia K Ketko, MD 9325 Upland Lane N, Suite 360, Maple Grove, MN 55369 Ph: (612) 813-6475 |
News Archive
Healthcare organizations are embracing the need for information transparency to drive clinical transformation, but they still require the tools and capabilities to make data available in real time and reduce the burden on scarce resources.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
IMRIS Inc. (TSX: IM) today announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia.
Just weeks after Sierra Leone discharged its last patient, a new study reflects on the lessons learnt from the recent outbreak of Ebola, comparing it with that of AIDS in Africa in the early 1980s.
Today Biogen Idec reported top-line results of EMPOWER, a Phase 3 trial investigating dexpramipexole in people with amyotrophic lateral sclerosis (ALS).
› Verified 7 days ago
Laura Woodbeck Moustafa, Pediatrics Medicare: Medicare Enrolled Practice Location: 12720 Bass Lake Rd, Maple Grove, MN 55369 Phone: 763-559-2861 | |
Dr. Susan K. Mahle, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12720 Bass Lake Rd, Maple Grove, MN 55369 Phone: 763-559-2861 Fax: 763-559-1338 | |
Pamela Jean Niksich, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12720 Bass Lake Rd, Maple Grove, MN 55369 Phone: 763-559-2861 Fax: 763-559-1338 | |
Gretchen A Voge, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9875 Hospital Dr, Maple Grove, MN 55369 Phone: 888-455-2229 | |
Aaron Wendell Swenson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9325 Upland Lane N, Suite 360, Maple Grove, MN 55369 Phone: 612-322-6903 | |
Jeanne D Mrozek, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9325 Upland Lane N, Suite 360, Maple Grove, MN 55369 Phone: 612-813-6475 | |
Dr. Rebecca A Doege, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 12720 Bass Lake Rd, Maple Grove, MN 55369 Phone: 414-266-2000 |